Sims J.R., Zimmer J.A., Evans C.D. et al., Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial, JAMA 330:512-527 (2023)

Cited by name. No followable URL — the bibliographic record is the citation.

Authors. Sims J.R., Zimmer J.A., Evans C.D. et al

Venue. JAMA 330:512-527

How the Institute flags it

established 1 time

Cited on 1 page

• Neurodegeneration Reversal